By Erik J. MacLaren, PhD Immunotherapy with anti-PD-L1/PD-1 antibodies is rapidly changing the therapeutic landscape for patients with non-small cell lung cancer (NSCLC). However, selecting the most optimal patient population […] Read more
By Gerard A. Silvestri, MD, MS, FCCP A recent population-based study suggested the incidence of pulmonary nodules detected by CT is around 1.5 million per year. This finding is no […] Read more
By James L. Mulshine, MD, PhD, Fred Hirsch, MD, PhD, and John K. Field, PhD, FRCPath Over the last fifteen years, the use of lowdose computed tomography (LDCT) for early […] Read more
By Nicola M. Parry, DVM From May 13 to 15, 2016, the 7th International Association for the Study of Lung Cancer (IASLC) Asia Pacific Lung Cancer Conference (APLCC) took place […] Read more
By: Corey J. Langer, MD, FACP Professor of Medicine University of Pennsylvania Editor, IASLC Lung Cancer News Welcome to the second issue of IASLC Lung Cancer News. In concert with the […] Read more
By Prof. Fabien Calvo, MD, PhD Today, cancer research is facing several challenges. The genomics era has ushered in a host of new molecular therapies; however, most of these targeted […] Read more
Dear Colleagues, We are inviting you to take part in the IASLC 17th World Conference on Lung Cancer in Vienna, December 4-7, 2016. This Conference will be the first of […] Read more
The David A. Karnofsky Memorial Award from the American Society of Clinical Oncology (ASCO) recognizes oncologists who have made outstanding contributions to the research, diagnosis, or treatment of cancer. Dr. […] Read more
• Clovis Oncology is shutting down patient enrollment in clinical trials of its lung cancer drug rociletinib, which targets T790m, a mutation responsible for acquired resistance in more than half […] Read more
Stefania Vallone
Stefania Vallone has been elected President of Lung Cancer Europe (LuCE), which provides a European platform for already existing lung cancer patient advocacy groups and supports the establishment of national […] Read more